Search results
Hims debuts $199 weight-loss shots at 85% discount to Wegovy
Detroit News· 7 days agoIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to...
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
InvestorPlace· 7 days agoHims & Hers has partnered with an undisclosed manufacturer of generic and 503B compounded injectable...
Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers -...
KTLA-TV Los Angeles· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the"Company") (NASDAQ: BIIB) and certain officers. The class action, filed ...
Congress to evaluate how to lower prescription prices by increasing competition
WFXT via Yahoo News· 6 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 hours ago(“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities ...
Hims & Hers is getting into the weight-loss drug game — and Wall Street is loving it
INSIDER via Yahoo News· 7 days agoWhile compounded drugs are generally considered safe, semaglutide is something of an unusual case in...
Congress evaluate how to lower prescription prices by increasing competition
WFTV via Yahoo News· 6 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Hims & Hers debuts $199 weight-loss shots at 85% discount to Wegovy
Modern Healthcare· 7 days agoThis will help customers access these drugs without “navigating the shortages and costs that are currently limiting access to the branded medications,” Hims said in a press release. The new, ...
Congress evaluate how to lower prescription prices by increasing competition
WJAX via Yahoo News· 6 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 6 days agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...